Interview: Anders Fogstrup, Country Manager, Norpharma, Denmark
Country Manager of Norpharma, Denmark, discusses how the company has been able to remain a market competitor while…
Norpharma, Denmark
Last updated: 13.02.2014
Norpharma A/S (Norpharma) is a pharmaceutical company engaged in the manufacture and marketing of pharmaceutical products. The company is a integral part of Napp Group. Norpharma principally focuses on developing medicines for the treatment of pain and cancer related problems. The product portfolio of the company include Prioderm, Hedrin, DoloTest and Order Todolac.
It has collaborated with cohn&wolfe company to develop new treatment principle for the control of persistent pain. It markets its products in domestic market through its own sales force and in international market through distributors. Norpharma is a headquartered in Horsholm, Denmark.
Norpharma A/S
Slotsmarken 15
2970 Hørsholm
Danmark
45 45 17 48 00
http://www.norpharma.dk/
Interviews
Related
Patrik Forsell – General Manager, Takeda Denmark
Industry veteran Patrik Forsell oversees Takeda’s operations in Denmark. Here, Forsell talks through how sizeable…
Linn Mandahl – General Manager, AbbVie Scandinavia
In a wide-ranging interview, AbbVie’s Linn Mandahl discusses how the reorganisation of Scandinavian operations…
Denmark / 5 Pharma Country Managers Talk Market Access
Long established as a premier early launch country for innovative medicines within Europe, the Danish market access…
Tore von Würden – Country Director Denmark & Iceland, Amgen
Tore von Würden talks through Amgen Denmark’s focus areas of osteoporosis, cardiovascular disease, haematology,…
Tashia Lentz – Managing Director, Biogen Denmark
Tashia Lentz of Biogen outlines what she sees as an increasingly tough market access environment for new treatments…
Catherine Williams – Managing Director, MSD Denmark & Iceland
MSD’s Catherine Williams, a recent arrival in Copenhagen, gives her first impressions of the Danish…
Julie Enevold Brooker – Country Director, Janssen Denmark
Julie Enevold Brooker discusses what she sees as Janssen’s responsibility to help improve the Danish healthcare…
Nicolas Dumoulin – General Manager & Head of Human Pharma, Boehringer…
Boehringer Ingelheim’s Nicolas Dumoulin outlines Denmark’s relevance to the German family-owned company,…
Flemming Sonne – CEO, Amgros, Denmark
Flemming Sonne of Denmark’s public hospital medicine procurement body Amgros outlines the scope and mission of…
Diana Arsovic Nielsen – Director, Danish Life Science Cluster
The Danish Life Science Cluster is Denmark’s new national business cluster for life science technology,…
Enrique Álvarez – Managing Director & General Manager, Merck Denmark
Spanish native Enrique Álvarez gives an overview of Denmark’s importance to Merck as a key European early launch…
Denmark / Data Crucial To Innovative Access Agreements
Established in 2017, the Danish Medicines Council is the health technology assessment (HTA)-like body in Denmark…
